These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17884189)

  • 1. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex.
    Peleg-Raibstein D; Feldon J
    Behav Brain Res; 2008 Jan; 186(1):12-22. PubMed ID: 17884189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex.
    Sorg BA; Davidson DL; Kalivas PW; Prasad BM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):54-61. PubMed ID: 9103480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioning in rats.
    Runyan JD; Dash PK
    Neurobiol Learn Mem; 2004 Sep; 82(2):65-70. PubMed ID: 15341790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.
    Lehner M; Taracha E; Turzyńska D; Sobolewska A; Hamed A; Kołomańska P; Skórzewska A; Maciejak P; Szyndler J; Bidziński A; Płaźnik A
    Behav Brain Res; 2008 Oct; 192(2):203-15. PubMed ID: 18499280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.
    Grant A; Hoops D; Labelle-Dumais C; Prévost M; Rajabi H; Kolb B; Stewart J; Arvanitogiannis A; Flores C
    Eur J Neurosci; 2007 Dec; 26(11):3215-28. PubMed ID: 18005074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats.
    Lemos JI; Resstel LB; Guimarães FS
    Behav Brain Res; 2010 Feb; 207(1):105-11. PubMed ID: 19800921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine locomotor sensitization is accompanied with an enhanced high K⁺-stimulated Dopamine release in the rat medial prefrontal cortex.
    Casanova JP; Velis GP; Fuentealba JA
    Behav Brain Res; 2013 Jan; 237():313-7. PubMed ID: 23047059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of contextual conditioned fear extinction after microinjection of alpha-1-adrenergic blocker prazosin into the medial prefrontal cortex.
    Do-Monte FH; Allensworth M; Carobrez AP
    Behav Brain Res; 2010 Jul; 211(1):89-95. PubMed ID: 20227443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.
    Bickerdike MJ; Abercrombie ED
    J Pharmacol Exp Ther; 1997 Aug; 282(2):818-26. PubMed ID: 9262346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-emergence of extinguished auditory-cued conditioned fear following a sub-conditioning procedure: effects of hippocampal and prefrontal tetanic stimulations.
    Deschaux O; Motanis H; Spennato G; Moreau JL; Garcia R
    Neurobiol Learn Mem; 2011 May; 95(4):510-8. PubMed ID: 21397708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex.
    Lin KY; Cherng CG; Yang FR; Lin LC; Lu RB; Yu L
    Behav Brain Res; 2011 Jun; 220(1):126-31. PubMed ID: 21277908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment.
    Peterson JD; Wolf ME; White FJ
    Synapse; 2000 Jun; 36(4):342-4. PubMed ID: 10819912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic activity in the medial prefrontal cortex modulates fear conditioning.
    Babaei P; Tehrani BS; Alizadeh A; Nakhostin M
    Acta Med Iran; 2011; 49(7):433-7. PubMed ID: 21960074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine D3 receptors in the expression of conditioned fear in rats.
    Swain SN; Beuk J; Heidbreder CA; Beninger RJ
    Eur J Pharmacol; 2008 Jan; 579(1-3):167-76. PubMed ID: 17996231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased conditioned fear response and altered balance of dopamine in the shell and core of the nucleus accumbens during amphetamine withdrawal.
    Pezze MA; Feldon J; Murphy CA
    Neuropharmacology; 2002 Apr; 42(5):633-43. PubMed ID: 11985821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-training amphetamine administration enhances memory consolidation in appetitive Pavlovian conditioning: Implications for drug addiction.
    Simon NW; Setlow B
    Neurobiol Learn Mem; 2006 Nov; 86(3):305-10. PubMed ID: 16750404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
    Carlson JN; Drew Stevens K
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1678-92. PubMed ID: 17010135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amygdala modulates prefrontal cortex activity relative to conditioned fear.
    Garcia R; Vouimba RM; Baudry M; Thompson RF
    Nature; 1999 Nov; 402(6759):294-6. PubMed ID: 10580500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal dopamine D4 receptors are involved in encoding fear extinction.
    Pfeiffer UJ; Fendt M
    Neuroreport; 2006 May; 17(8):847-50. PubMed ID: 16708027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.